In the first successful United States trial of a bioabsorbable polymer stent, the Boston Scientific Synergy everolimus-eluting bioabsorbable polymer platinum chromium coronary stent system met its primary endpoint in this non-inferiority study, which evaluated the one-year rate of target lesion failure (TLF).

Medtronic Inc. announced the launch in Europe and the United States of the Endurant IIs AAA stent graft, which received CEĀ mark and U.S. Food and Drug Administration approval to be used in the minimally invasive treatment of abdominal aortic aneurysms (AAA).

Stethoscope provides high acoustic sensitivity for performing general physical assessments

Subscribe to
Ā© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now